GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 1.03 | -4.97 | -10.6 | -0.59 | 0.36 | -3.02 | |||
Changes by years, y/y, % | -78% | -585% | +113% | -94% | -161% | -46.2% |
GoodRx Holdings. Debt/EBITDA
GoodRx Holdings. Debt/EBITDA, changes, %
GoodRx Holdings (GDRX) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | -0.91 | 0.37 | 1.64 | 1.78 | -3.02 | -3.02 | ||
Changes by years, y/y, % | +95% | -161% | -338% | -465% | +231% | |||
Changes by quarters, q/q, % | +88% | -141% | +337% | +9% | -270% |